CJC-1295: The Growth Hormone Releasing Peptide Driving Anti-Aging Research

CJC-1295 is a GHRH analogue studied for sustained growth hormone release and applications in anti-aging, body composition, and performance research.

Source: SONOCOUTURE

TL;DR: CJC-1295 is a GHRH analogue studied for sustained growth hormone release in anti-aging and body composition research.

What this page covers

CJC-1295: The Growth Hormone Releasing Peptide Driving Anti-Aging Research

CJC-1295 is a GHRH analogue examined for sustained growth hormone release in anti-aging and body composition research.

CJC-1295 - SONOCOUTURE - GHRH analogue studied for sustained growth hormone release

Article Content

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone that is studied for its relationship to growth hormone production and release.

Facts Index

Entity Attribute Value Confidence
CJC-1295: The Growth Hormone Releasing Peptide Driving Anti-Aging Research author LAURE ZOYA high
CJC-1295: The Growth Hormone Releasing Peptide Driving Anti-Aging Research publish_date 2026-05-07T11:02:35Z high

Who Is This For

Frequently Asked Questions

What is CJC-1295?

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone studied for growth hormone release.

What research areas are associated with CJC-1295?

CJC-1295 is associated with anti-aging, body composition, and performance research.

Who authored the CJC-1295 article?

The CJC-1295 article author is LAURE ZOYA.

When was the CJC-1295 article published?

The CJC-1295 article publication date is 2026-05-07.